Cargando…
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis
To date, no comprehensive analysis of autoantibodies in sera of patients with ulcerative colitis has been conducted. To analyze the spectrum of autoantibodies and to elucidate their role serum-IgG from UC patients (n = 49) and non-UC donors (n = 23) were screened by using a human protein microarray....
Autores principales: | Jodeleit, Henrika, Milchram, Lisa, Soldo, Regina, Beikircher, Gabriel, Schönthaler, Silvia, Al-amodi, Omar, Wolf, Eckhard, Beigel, Florian, Weinhäusel, Andreas, Siebeck, Matthias, Gropp, Roswitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015398/ https://www.ncbi.nlm.nih.gov/pubmed/32050001 http://dx.doi.org/10.1371/journal.pone.0228615 |
Ejemplares similares
-
CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
por: Al-amodi, Omar, et al.
Publicado: (2018) -
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
por: Jodeleit, Henrika, et al.
Publicado: (2018) -
A mouse model for ulcerative colitis based on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells from affected individuals
por: Palamides, Pia, et al.
Publicado: (2016) -
Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model
por: Jodeleit, Henrika, et al.
Publicado: (2017) -
The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ (null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab
por: Jodeleit, Henrika, et al.
Publicado: (2020)